Qualifications and history
2004 PhD, Cambridge University, UK
2004 Postdoctoral Fellow, European Molecular Biology Laboratory, Germany
2006 Visiting Scientist, Research Institute of Molecular Pathology, Austria
2007 Established lab at the London Research Institute, Cancer Research UK
2015 Group Leader, the Francis Crick Institute, London, UK
Dr Barry Thompson was a graduate student at the Medical Research Council Laboratory for Molecular Biology (MRC LMB) in Cambridge, where he studied the Wnt signalling pathway in Drosophila in the lab of Dr Mariann Bienz.
Barry then moved to the European Molecular Biology Laboratory (EMBL) to the lab of Professor Stephen Cohen, where he used Drosophila genetics to study Hippo signalling and tumour formation. Subsequently, he visited the Institute for Molecular Pathology in Vienna, where he performed an in vivo RNAi screen in Drosophila in the lab of Dr Barry Dickson.
In 2007, he established his own lab at the Cancer Research UK London Research Institute, which became part of the Crick in 2015. He and his team are studying the genes that control tissue growth and form in Drosophila and translating these findings into mouse models.
Dr Thompson received the EMBO Young Investigator Award in 2011 and was recently appointed as a Wellcome Trust Investigator.